This issue of the ECDC Communicable Disease Threats Report (CDTR) covers the period 28 September - 4 October 2024 and includes updates on Marburg virus disease, Mpox, avian influenza A(H5N1) human cases, an overview of respiratory virus epidemiology in the EU/EEA, West Nile virus, dengue, SARS-CoV-2, MERS-CoV, and chikungunya.
On 2 October 2024, Germany reported that two travellers returning from Rwanda were isolated in Hamburg due to a history of exposure in a medical facility in Rwanda where Marburg virus disease patients were being treated. ECDC has been in close contact with German public health authorities. Negative test results were reported on 3 October 2024.
This ECDC survey protocol describes the technical requirements for implementing a genomic surveillance-based survey of CRAb isolates from patients seeking hospital care. It is intended for first use in 2024–2025.
This technical report is a laboratory manual that accompanies the ‘Survey protocol for the ECDC genomic-based surveillance of carbapenem-resistant Acinetobacter baumannii in Europe’.
Marburg virus disease, formerly known as Marburg haemorrhagic fever, is a severe disease in humans. Although the disease is uncommon, it has the potential to cause epidemics with significant case fatality rates.
